Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB

By LabMedica International staff writers
Posted on 06 Feb 2020
GeneMatrix (Seoul, South Korea) promoted its main NeoPlex family of sex and respiratory infection testing products, at MEDLAB Middle East, which took place from 3-6 February 2020 at the Dubai World Trade Centre. More...
MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, drew over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries.

GeneMatrix focuses on leading the personalized medicine business through the development of competitive platforms and molecular diagnosis products. GeneMatrix’s proprietary RFMP platform technology can derive values from the genetic information of living creatures. The RFMP technology embodies unparalleled specifications for precision, sensitivity, digitalized quantitative analysis, multi-biomarker’s batch analysis and large quantity sample processing. The elements of biotechnology, nanotechnology and IT technology are organically fused in RFMP technology, and it is now being widely used. Its utilization will be extended to early diagnosis, prognosis determination, selection of therapeutic agent, treatment reaction monitoring for chronic intractable diseases including infectious, metabolic, neoplastic and genetic diseases.

At MEDLAB Middle East 2020, promoted sex and respiratory infection testing products of its main pipeline, NeoPlex, which are based om the company's original C-Tag technology. GeneMatrix offers multiple products in its respiratory testing line. In the respiratory virus panel line, it has developed NeoPlex RV-Panel A and NeoPlex RV-Panel B, while in the bacterial panel line it has developed NeoPlex RB-8.

GeneMatrix’s NeoPlex RV-Panel A is capable of collectively diagnosing 10 major respiratory viral pathogens, including influenza A/B, respiratory syncytial virus A/B, parainfluenza 1/2/3, and adenovirus, in a single test. Its NeoPlex RV-Panel B can simultaneously diagnose nine respiratory viruses, including coronavirus, enterovirus, and rhinovirus. GeneMatrix has completed the clinical trials of NeoPlex RV-Panel B which is ready for early market release.

Related Links:
GeneMatrix


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.